The REVOX Sterilization Solutions process uses a patented, room-temperature vaporized peracetic acid (VPA) sterilant that achieves exceptionally low chemical residuals and unsurpassed materials compatibility. Manufacturers can create the products that will demonstrate their true potential.
REVOX completed tests on over 100 different materials, such as thermoplastics, thermosets, adhesives, elastomers, metals, ceramics/glass, bio-absorbable items, electronics and batteries.
REVOX Sterilization Solutions' technology eliminates inefficiencies associated with pre-conditioning and lengthy post sterilization wait times. This allows REVOX to offer manufacturers options; a quick-turn, off-site sterilization service, or JUST-IN-TIME STERILIZATIONSM lean, cost efficient in-line processing.
In May 2014, the FDA granted clearance for a Class II implantable device with the REVOX sterilization process. The REVOX innovation is backed by a company with over 35 years of infection prevention and control advancements structured under strict regulatory compliance standards.
Sterilization hasn't changed in decades. We're making up for lost time.